MSTFX
Price
$9.93
Change
+$0.06 (+0.61%)
Updated
Jan 17 closing price
Net Assets
830.13M
VDIPX
Price
$24.43
Change
+$0.10 (+0.41%)
Updated
Jan 17 closing price
Net Assets
191.39B
Ad is loading...

MSTFX vs VDIPX

Header iconMSTFX vs VDIPX Comparison
Open Charts MSTFX vs VDIPXBanner chart's image
Morningstar International Equity
Price$9.93
Change+$0.06 (+0.61%)
VolumeN/A
Net Assets830.13M
Vanguard Developed Markets Index Ins Pls
Price$24.43
Change+$0.10 (+0.41%)
VolumeN/A
Net Assets191.39B
MSTFX vs VDIPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSTFX vs. VDIPX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSTFX is a Buy and VDIPX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VDIPX has more cash in the bank: 191B vs. MSTFX (830M). VDIPX pays higher dividends than MSTFX: VDIPX (3.28) vs MSTFX (2.33). MSTFX was incepted earlier than VDIPX: MSTFX (6 years) vs VDIPX (11 years). MSTFX is a more actively managed with annual turnover of: 21.00 vs. VDIPX (3.00). MSTFX has a lower initial minimum investment than VDIPX: MSTFX (0) vs VDIPX (100000000). VDIPX annual gain was more profitable for investors over the last year : 4.88 vs. MSTFX (4.42). VDIPX return over 5 years is better than : 11.64 vs. MSTFX (-5.14).
MSTFXVDIPXMSTFX / VDIPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years11 years-
Gain YTD1.0171.58064%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets830M191B0%
Annual Yield % from dividends2.333.2871%
Returns for 1 year4.424.8891%
Returns for 3 years-6.71-2.33288%
Returns for 5 years-5.1411.64-44%
Returns for 10 yearsN/A35.10-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANSS349.935.51
+1.60%
ANSYS
INSE9.470.14
+1.50%
Inspired Entertainment
BCAB0.490.01
+1.46%
BioAtla
UMH18.280.06
+0.33%
UMH Properties
VRNA51.89-1.75
-3.26%
Verona Pharma plc